These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 25702651

  • 1. Analysis of microRNA expression profile identifies novel biomarkers for non-small cell lung cancer.
    Xu C, Zheng Y, Lian D, Ye S, Yang J, Zeng Z.
    Tumori; 2015; 101(1):104-10. PubMed ID: 25702651
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
    Chen YJ, Guo YN, Shi K, Huang HM, Huang SP, Xu WQ, Li ZY, Wei KL, Gan TQ, Chen G.
    Respir Res; 2019 Mar 04; 20(1):48. PubMed ID: 30832674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
    Li YB, Lin LZ, Guan JS, Chen CM, Zuo Q, Lin BQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep 04; 36(9):1076-1081. PubMed ID: 30645846
    [Abstract] [Full Text] [Related]

  • 8. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.
    Tumour Biol; 2016 Sep 04; 37(9):11927-11936. PubMed ID: 27075472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of featured biomarkers in breast cancer with microRNA microarray.
    Zhang M, Liu D, Li W, Wu X, Gao C, Li X.
    Arch Gynecol Obstet; 2016 Nov 04; 294(5):1047-1053. PubMed ID: 27365106
    [Abstract] [Full Text] [Related]

  • 16. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.
    Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, Liu X, Zhang Y, Le H.
    PLoS One; 2014 Nov 04; 9(2):e87780. PubMed ID: 24523873
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 04; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 20. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 04; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.